** Pfizer's PFE.N shares rise 1.7% to $23.44 premarket
** PFE posts Q1 adj EPS of $0.92, beating analysts' estimates of $0.67, per data compiled by LSEG
** While Q1 revenue misses estimates, but still sticks by FY revenue forecast of $61-$64 billion
** Also maintains FY adj EPS outlook of $2.80-$3.00
** As of last close, PFE has fallen about 13% YTD
(Reporting by Siddhi Mahatole)
((siddhi.mahatole@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。